...
search icon
adxn-img

Addex Therapeutics Ltd Share Price

ADXN
NAQ
$7.314
+$0
(0%)
1D
Industry: Biotechnology Sector: Health Care

Addex Therapeutics Ltd Analyst Forecast

Addex Therapeutics Ltd Share Price Chart

Addex Therapeutics Ltd Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.01M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
264.00
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.94
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.51 L
$12.05 H
$7.314

About Addex Therapeutics Ltd, Common Stock

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland. more

Industry: BiotechnologySector: Health Care

Addex Therapeutics Ltd Stock Returns

Time FrameADXNSectorS&P500
1-Week Return-5.25%0.72%-1.31%
1-Month Return-11.12%1.27%0.78%
3-Month Return-18.36%3.13%3.46%
6-Month Return-9.52%15.81%6.19%
1-Year Return0.07%8.89%11.68%
3-Year Return-81.43%20.79%71.21%
5-Year Return-97.02%35.89%74.81%
10-Year Return-97.48%138.44%256.59%

Addex Therapeutics Ltd Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue3.61M2.92M1.42M1.61M404.10K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":80.72,"profit":true},{"date":"2022-12-31","value":39.37,"profit":true},{"date":"2023-12-31","value":44.65,"profit":true},{"date":"2024-12-31","value":11.19,"profit":true}]
Cost of Revenue10.37M12.82M14.62M6.94M854.30K[{"date":"2020-12-31","value":70.94,"profit":true},{"date":"2021-12-31","value":87.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":47.43,"profit":true},{"date":"2024-12-31","value":5.84,"profit":true}]
Gross Profit3.61M2.92M1.42M1.61M404.10K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":80.72,"profit":true},{"date":"2022-12-31","value":39.37,"profit":true},{"date":"2023-12-31","value":44.65,"profit":true},{"date":"2024-12-31","value":11.19,"profit":true}]
Gross Margin100.00%100.00%100.00%100.00%100.00%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses15.86M18.42M11.96M3.86M3.16M[{"date":"2020-12-31","value":86.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.94,"profit":true},{"date":"2023-12-31","value":20.93,"profit":true},{"date":"2024-12-31","value":17.15,"profit":true}]
Operating Income(12.24M)(15.51M)(10.54M)(2.24M)(2.76M)[{"date":"2020-12-31","value":-1224327400,"profit":false},{"date":"2021-12-31","value":-1550591700,"profit":false},{"date":"2022-12-31","value":-1054090100,"profit":false},{"date":"2023-12-31","value":-224296700,"profit":false},{"date":"2024-12-31","value":-275523300,"profit":false}]
Total Non-Operating Income/Expense(649.52K)96.31K(282.70K)(214.83K)(2.15M)[{"date":"2020-12-31","value":-674.39,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-293.52,"profit":false},{"date":"2023-12-31","value":-223.05,"profit":false},{"date":"2024-12-31","value":-2230.74,"profit":false}]
Pre-Tax Income(12.86M)(15.35M)(10.80M)(2.50M)(4.91M)[{"date":"2020-12-31","value":-1285859900,"profit":false},{"date":"2021-12-31","value":-1535191400,"profit":false},{"date":"2022-12-31","value":-1080395600,"profit":false},{"date":"2023-12-31","value":-250015300,"profit":false},{"date":"2024-12-31","value":-490934200,"profit":false}]
Income Taxes207.76K116.38K123.91K21.61K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.01,"profit":true},{"date":"2022-12-31","value":59.64,"profit":true},{"date":"2023-12-31","value":10.4,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(13.07M)(15.47M)(10.93M)(2.52M)-[{"date":"2020-12-31","value":-1306636100,"profit":false},{"date":"2021-12-31","value":-1546829100,"profit":false},{"date":"2022-12-31","value":-1092786600,"profit":false},{"date":"2023-12-31","value":-252176000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(12.86M)(15.35M)(20.80M)(10.56M)(4.91M)[{"date":"2020-12-31","value":-1285859900,"profit":false},{"date":"2021-12-31","value":-1535191400,"profit":false},{"date":"2022-12-31","value":-2080421300,"profit":false},{"date":"2023-12-31","value":-1055622700,"profit":false},{"date":"2024-12-31","value":-490934200,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.86M)(15.35M)(20.80M)(10.56M)7.06M[{"date":"2020-12-31","value":-182.24,"profit":false},{"date":"2021-12-31","value":-217.58,"profit":false},{"date":"2022-12-31","value":-294.85,"profit":false},{"date":"2023-12-31","value":-149.61,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(0.87)(2.99)(3.57)--[{"date":"2020-12-31","value":-87.3,"profit":false},{"date":"2021-12-31","value":-299,"profit":false},{"date":"2022-12-31","value":-357.36,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Addex Therapeutics Ltd Ratios

Addex Therapeutics Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ADXN
Cash Ratio 1.87
Current Ratio 2.01

Addex Therapeutics Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ADXN
ROA (LTM) -15.90%
ROE (LTM) -72.84%

Addex Therapeutics Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ADXN
Debt Ratio Lower is generally better. Negative is bad. 0.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.81

Addex Therapeutics Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ADXN
Trailing PE NM
Forward PE NM
P/S (TTM) 56.84
P/B 1.20
Price/FCF NM
EV/R 165.71
EV/Ebitda NM

FAQs

What is Addex Therapeutics Ltd share price today?

Addex Therapeutics Ltd (ADXN) share price today is $7.314

Can Indians buy Addex Therapeutics Ltd shares?

Yes, Indians can buy shares of Addex Therapeutics Ltd (ADXN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADXN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Addex Therapeutics Ltd be purchased?

Yes, you can purchase fractional shares of Addex Therapeutics Ltd (ADXN) via the Vested app. You can start investing in Addex Therapeutics Ltd (ADXN) with a minimum investment of $1.

How to invest in Addex Therapeutics Ltd shares from India?

You can invest in shares of Addex Therapeutics Ltd (ADXN) via Vested in three simple steps:

  • Click on Sign Up or Invest in ADXN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Addex Therapeutics Ltd shares
What is Addex Therapeutics Ltd 52-week high and low stock price?

The 52-week high price of Addex Therapeutics Ltd (ADXN) is $12.05. The 52-week low price of Addex Therapeutics Ltd (ADXN) is $6.51.

What is Addex Therapeutics Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Addex Therapeutics Ltd (ADXN) is

What is Addex Therapeutics Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Addex Therapeutics Ltd (ADXN) is 1.20

What is Addex Therapeutics Ltd dividend yield?

The dividend yield of Addex Therapeutics Ltd (ADXN) is 0.00%

What is the Market Cap of Addex Therapeutics Ltd?

The market capitalization of Addex Therapeutics Ltd (ADXN) is $9.01M

What is Addex Therapeutics Ltd's stock symbol?

The stock symbol (or ticker) of Addex Therapeutics Ltd is ADXN

How Can Investors Use Addex Therapeutics Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of Addex Therapeutics Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Addex Therapeutics Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Addex Therapeutics Ltd shares for Indian investors?

When investing in Addex Therapeutics Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Addex Therapeutics Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Addex Therapeutics Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of Addex Therapeutics Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Addex Therapeutics Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top